Literature DB >> 856868

Renal tubular effects of chronic phosphate depletion.

S Goldfarb, G R Westby, M Goldberg, Z S Agus.   

Abstract

The effects of chronic phosphate depletion on renal tubular function were evaluated by micropuncture and free water clearance studies in the dog. Proximal tubular punctures demonstrated that chronic hypophosphatemia led to a reduction in ratio of tubular fluid to plasma inulin in late superficial tubular from 1.59+/-0.08 in control animals to 1.29+/-0.06 in phosphate-depleted dogs, with proportional inhibition of calcium and sodium reabsorption. The chronic decrease in proximal tubular fluid reabsorption was confirmed by the analysis of sustained water diuresis in conscious, phosphate-depleted dogs, before and after repletion of body PO4 stores, and in control animals. Urine flow rate/100 ml glomerular filtration rate (V/GFR) was significantly higher in PO4 DEPLETION THAN CONTROL (15.8+/-1.1 VS. 10.7+/-0.82). In addition, acetazolamide infusion did not increase V/GFR in phosphate-depleted dogs (15.8+/-1.1 vs. 17.16+/-0.9), supporting the conclusion that inhibition of proximal tubular fluid reabsorption was responsible for the elevated urine flow rate. PO4 repletion over 5 days reduced V/GFR to 9.2+/-0.7 despite no change in urine osmolality and no change in GFR, further suggesting a specific reversible alteration in proximal tubular reabsorption in phosphate depletion. Although hypercalciuria was a constant finding in phosphate depletion (fractional excretion of calcium of 2.04+/-0.4% vs. 0.47+/-0.13% in controls), the enhanced distal delivery of calcium was not a crucial factor; acute phosphate infusion reduced urinary calcium excretion to control values without affecting the reduced proximal tubular reabsorption in either intact or thyroparathyroidectomized phosphate-depleted dogs the change in distal nephron calcium reabsorption was independent of parathyroid hormone (PTH) levels since infusion of PTH failed to alter urinary calcium excretion. We conclude that chronic phosphate depletion leads to a reversible, sustained inhibition in proximal tubular reabsorptive fuction as well as a specific decrease in distal nephron calcium reabsorption. This latter reabsorptive defect is sensitive to phosplate infusion but not corrected by PTH.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856868      PMCID: PMC372284          DOI: 10.1172/JCI108698

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  The effects of glucose and insulin on renal electrolyte transport.

Authors:  R A DeFronzo; M Goldberg; Z S Agus
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

2.  Influence of dietary phosphorus on renal phosphate reabsorption in the parathyroidectomized rat.

Authors:  T H Steele; H F DeLuca
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

3.  Reversible changes of the muscle cell in experimental phosphorus deficiency.

Authors:  T J Fuller; N W Carter; C Barcenas; J P Knochel
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

4.  Mode of action of parathyroid hormone and cyclic adenosine 3',5'-monophosphate on renal tubular phosphate reabsorption in the dog.

Authors:  Z S Agus; J B Puschett; D Senesky; M Goldberg
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

5.  Acute hemolytic anemia with rigid red cells in hypophosphatemia.

Authors:  H S Jacob; T Amsden
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

6.  Evidence for a phosphorus-depletion syndrome in man.

Authors:  M Lotz; E Zisman; F C Bartter
Journal:  N Engl J Med       Date:  1968-02-22       Impact factor: 91.245

7.  Reduced red cell glycolysis, 2, 3-diphosphoglycerate and adenosine triphosphate concentration, and increased hemoglobin-oxygen affinity caused by hypophosphatemia.

Authors:  M A Lichtman; D R Miller; J Cohen; C Waterhouse
Journal:  Ann Intern Med       Date:  1971-04       Impact factor: 25.391

8.  Studies of the mechanism by which chronic metabolic acidosis augments urinary calcium excretion in man.

Authors:  J Lemann; J R Litzow; E J Lennon
Journal:  J Clin Invest       Date:  1967-08       Impact factor: 14.808

9.  The pathophysiology of acid-base changes in chronically phosphate-depleted rats: bone-kidney interactions.

Authors:  M Emmett; S Goldfarb; Z S Agus; R G Narins
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

10.  Renal bicarbonate wasting during phosphate depletion. A possible cause of altered acid-base homeostasis in hyperparathyroidism.

Authors:  L W Gold; S G Massry; A I Arieff; J W Coburn
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

View more
  7 in total

1.  Impaired distal nephron acidification in chronically phosphate depleted rats.

Authors:  T W Kurtz; C H Hsu
Journal:  Pflugers Arch       Date:  1978-11-30       Impact factor: 3.657

Review 2.  Renal handling of calcium and phosphate.

Authors:  F Lang
Journal:  Klin Wochenschr       Date:  1980-10-01

3.  Role of alcohol in clinical nephrology.

Authors:  A Heidland; W H Hörl; R M Schaefer; M Teschner; J Weipert; E Heidbreder
Journal:  Klin Wochenschr       Date:  1985-09-16

4.  Reversible depression in myocardial performance in dogs with experimental phosphorus deficiency.

Authors:  T J Fuller; W W Nichols; B J Brenner; J C Peterson
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

5.  Effect of phosphate depletion on magnesium homeostasis in rats.

Authors:  W J Kreusser; K Kurokawa; E Aznar; E Sachtjen; S G Massry
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

Review 6.  A survey of calcium urolithiasis in normocalcemic hypercalciuria: possible role of nutrients and diet-mediated factors.

Authors:  P O Schwille
Journal:  Urol Res       Date:  1979-09

7.  Renal tubular sites of altered calcium transport in phosphate-depleted rats.

Authors:  K Lau; Z S Agus; M Goldberg; S Goldfarb
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.